Circulating Brain Microvascular Endothelial Cells (cBMECs) as Potential Biomarkers of the Blood-Brain Barrier Disorders Caused by Microbial and Non-Microbial Factors

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Huang, Sheng He ^a,b   Wang, Lin ^a,c   Chi, Feng ^a   Wu, Chun Hua ^a   Cao, Hong ^b   Zhang, Aimin ^a,d   Jong, Ambrose ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

^d BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CD133 ANTIGEN; CD146 ANTIGEN; GLYCOPROTEIN GP 120; METHAMPHETAMINE; NICOTINE; PROTEIN S100B; UBIQUITIN THIOLESTERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER DISORDER; CELL ISOLATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; STEM CELL; TRANSCYTOSIS; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; CELL MOVEMENT; CELL SEPARATION; ENDOTHELIAL CELLS; ESCHERICHIA COLI; HIV ENVELOPE PROTEIN GP120; HIV-1; MAGNETICS; METHAMPHETAMINE; MICE; MICROSPHERES; MICROVESSELS; MODELS, BIOLOGICAL; NICOTINE; PERMEABILITY; RECEPTORS, NICOTINIC; STEM CELLS; TRANSCYTOSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 84876863732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062164     Document Type: Article

References (69)

1. Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF, (2009) Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs. 23: 35-58.
2. Begley DJ (2006) Structure and Function of the Blood-brain barrier. In "Enhancement in Drug Delivery" (Ed. by E. Touitou & BW Barry). CRC Press, p.575-589.
3. Manda KR, Banerjee A, Banks WA, Ercal N, (2011) Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells. Free Radic Biol Med. 50: 801-10.
4. Lamers SL, Gray RR, Salemi M, Huysentruyt LC, McGrath MS, (2011) HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol. 11: 31-7.
5. Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR, (2011) Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Res. 1399: 96-115.
6. Friedman H, Newton C, Klein TW, (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev. 16: 209-19.
7. Huang SH, Wass CA, Fu Q, Prasadarao NA, Stins MF, et al. (1995) Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10, Infect. Immun. 63: 4470-4475.
8. Huang SH, Stins MF, Kim KS, (2000) Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes and Infection 2: 1237-1244.
9. Stins MF, Shen Y, Huang SH, Gilles F, Kalra VK, et al. (2001) Gp120 activates children's.brain endothelial cells via CD4. J. Neurovirol 7: 125-34.
10. Chen YH, Chen HM, Zhou ZY, Li W, Jong AY, et al. (2002) Enhanced Escherichia coli invasion of human brain microvascular endothelial cells is associated with alterations in cytoskeleton induced by nicotine. Cell Microbiol. 4: 503-14.
11. Kim KS, (2003) Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 4: 376-385.
12. Jong A, Wu CH, Jiang S, Feng L, Chen HM, et al. (2007) HIV-1 gp41 ectodomain enhances Cryptococcus neoformans binding to HBMEC. Biochem Biophys Res.Commun. 356: 899-905.
13. Jong A, Wu CH, Zhou W, Chen HM, Huang SH, (2008) Infectomic analysis of gene expression profiles of human.brain microvascular endothelial cells infected with Cryptococcus neoformans. J BiomedBiotechnol (2008): 375620.
14. Chi F, Wang L, Zheng XY, Wu CH, Jong A, et al. (2011) Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptor. PLoS One. 6: e25016.
15. Chi F, Wang L, Zheng X, Jong A, Huang SH. Recruitment of α7 nicotinic acetylcholine receptor to caveolin-1-enriched lipid rafts is required for nicotine-enhanced Escherichia coli K1 entry into brain endothelial cells. Future Microbiol. 2011, 6: 953-66. PMID: 21861625.
16. Huang SH, Wu CH, Jiang SB, Bahner I, Lossinsky AS, et al. (2011) HIV-1 gp41 ectodomain enhances C. neoformans binding to human brain microvascular endothelial cells via gp41 core-induced membrane activities. Biochem J. 438: 457-66.
17. Chi F, Bo T, Wu CH, Jong A, Huang SH, (2012) Vimentin and PSF Act in Concert to Regulate IbeA+ E. coli K1 Induced Activation and Nuclear Translocation of NF-κB in Human Brain Endothelial Cells. PLoS One. 7: e35862.
18. Huang SH, Wu CH, Chang YC, Kwon-Chung KJ, Brown RJ, et al. (2012) Cryptococcus neoformans-Derived Microvesicles Enhance the Pathogenesis of Fungal Brain Infection. PLoS One. 7: e48570.
19. Olsen Al, Morrey JD, Smee DF, Sidwell RW, (2007) Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. Antiviral Res. 75: 104-112.
20. Lelyveld VS, Atanasijevic T, Jasanoff A, (2010) Challenges for Molecular Neuroimaging with MRI. Int J Imaging Syst Technol. 20: 71-79.
21. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, et al. (2005) Circulating endothelial cells: Biomarkers of vascular disease. Thromb Haemost. 93: 228-35.
22. Strijbos MH, Gratama JW, Kraan J, Lamers CH, den Bakker MA, et al. (2008) Circulating endothelial cells in oncology: pitfalls and promises. Br J Cancer 98: 1731-1735.
23. Haubitz M, Dhaygude A, Woywodt A, (2009) Mechanisms and markers of vascular damage in ANCA-associated vasculitis. Autoimmunity 42: 605-14.
24. Kraan J, Sleijfer S, Foekens JA, Gratama JW, (2012) Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today 17: 710-7.
25. Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD, (2006) Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia. 8: 79-88.
26. Bertolini F, Shaked Y, Mancuso P, Kerbel RS, (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6: 835-45.
27. Foster W, Shantsila E, Carruthers D, Lip GY, Blann AD, (2009) Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction. Rheumatology (Oxford) 48: 285-8.
28. Steiner J, Bernstein HG, Bielau H, Berndt A, Brisch R, et al. (2007) Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 8: 2.
29. Liu L, Liu H, Jiao J, Liu H, Bergeron A, et al. (2007) Changes in circulating human endothelial progenitor cells after brain injury. J Neurotrauma 24: 936-43.
30. Bogoslovsky T, Chaudhry A, Latour L, Maric D, Luby M, et al. (2010) Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 75: 2059-62.
31. Zhang X, Winkles JA, Gongora MC, Polavarapu R, Michaelson JS, et al. (2007) TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J Cereb Blood Flow Metab 27: 534-544.
32. Lee JD, Tsai LY, Chen CH, Wang JJ, Hsiao JK, et al. (2006) Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. Acta Trop 97: 204-11.
33. Miric D, Katanic R, Kisic B, Zoric L, Miric B, et al. (2010) Oxidative stress and myeloperoxidase activity during bacterial meningitis: effects of febrile episodes and the BBB permeability. Clin Biochem 43: 246-52.
34. Blyth BJ, Farahvar A, He H, Nayak A, Yang C, et al. (2011) Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury. J Neurotrauma 28: 2453-62.
35. Jackson CJ, Garbett PK, Nissen B, Schrieber L, (1990) Binding of human endothelium to Ulex europaeus I-coated Dynabeads: application to the isolation of microvascular endothelium. J Cell Sci 96: 257-262.
36. Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, et al. (2004) Janigro D. Peripheral markers of blood-brain barrier damage. Clin Chim Acta. 342: 1-12.
37. Zhong JF, Chen Y, Marcus JS, Scherer A, Quake SR, et al. (2008) Taylor CR, Weiner LP. A microfluidic processor for gene expression profiling of single human embryonic stem cells. Lab Chip 8: 68-74.
38. Leslie M, (2011) News Focus: The power of One. Science 331: 24-26.
39. Ståhlberg A, Kubista M, Aman P, (2011) Single-cell gene-expression profiling and its potential diagnostic applications. Expert Rev Mol Diagn 11: 735-40.
40. Kalisky T, Quake SR, (2011) Single cell genomics. Nat Methods 8: 311-4.
41. Fritzsch FS, Dusny C, Frick O, Schmid A, (2012) Single-Cell Analysis in Biotechnology, Systems Biology, and Biocatalysis. Annu Rev Chem Biomol Eng 3: 129-55.
42. Jung KH, Roh JK, (2008) Circulating Endothelial Progenitor Cells in Cerebrovascular Disease. J Clin Neurol 4: 139-147.
43. Fink K, Schwarz M, Feldbrügge L, Sunkomat JN, Schwab T, et al. (2010) Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation. Crit Care 14: R104.
44. Porto I, Leone AM, De Maria GL, Craig CH, Tritarelli A, et al. (2011) Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study. Atherosclerosis 216: 355-8.
45. Rouhl RPW, van Oostenbrugge RJ, Damoiseaux JG, Debrus-Palmans LL, Theunissen RO, et al. (2009) Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr Neurovasc Res 6: 32-41.
46. Deanfield JE, Halcox JP, Rabelink TJ, (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation. 115: 1285-95.
47. Esteve-Rudd J, Campello L, Herrero MT, Cuenca N, Martín-Nieto J, (2010) Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Brain Res 1352: 70-82.
48. Day IN, Thompson RJ, (2010) UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Prog Neurobiol. 90: 327-62.
49. Mitra S, Sammani S, Wang T, Boone DL, Meyer NJ, et al. (2011) Role of growth arrest and DNA damage-inducible α in Akt phosphorylation and ubiquitination after mechanical stress-induced vascular injury. Am J Respir Crit Care Med 184: 1030-40.
50. Zhong J, Zhao M, Ma Y, Luo Q, Liu J, Wang J, et al. (2012) UCHL1 acts as a colorectal cancer oncogene via activation of the β-catenin/TCF pathway through its deubiquitinating activity. Int J Mol Med. 30: 430-6.
51. Sacco JJ, Coulson JM, Clague MJ, Urbé S, (2010) Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life. 62: 140-57.
52. Takami Y, Nakagami H, Morishita R, Katsuya T, Cui TX, et al. (2007) Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation. Arterioscler Thromb Vasc Biol 27: 2184-90.
53. Northrop NA, Smith LP, Yamamoto BK, Eyerman DJ, (2011) Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals. J Pharmacol Exp Ther 336: 900-7.
54. Pendyala G, Buescher JL, Fox HS, (2012) Methamphetamine and inflammatory cytokines increase neuronal Na+/K+-ATPase isoform 3: relevance for HIV associated neurocognitive disorders. PLoS One. 7: e37604.
55. Ballester LY, Capó-Vélez CM, García-Beltrán WF, Ramos FM, Vázquez-Rosa E, et al. (2012) Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder. J Biol Chem. 287: 3079-86.
56. Zhang Y, Wang M, Li H, Zhang H, Shi Y, Wei F, et al. (2012) Brain Res. Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disorders (1458): 1-11.
57. Slominski A, (2010) Nicotinic receptor signaling in nonexcitable epithelial cells: paradigm shifting from ion current to kinase cascade. Focus on "Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases". Am J Physiol Cell Physiol. 299: C885-7.
58. Tsoporis JN, Izhar S, Proteau G, Slaughter G, Parker TG, (2012) S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. J Mol Cell Cardiol. 52: 464-73.
59. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, et al. (2006) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190: 269-319.
60. Martinez LR, Mihu MR, Gácser A, Santambrogio L, Nosanchuk JD, (2009) Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis 200: 131-41.
61. Banerjee A, Zhang X, Manda KR, Banks WA, Ercal N, (2010) HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic Biol Med 48: 1388-98.
62. Loram LC, Harrison JA, Chao L, Taylor FR, Reddy A, et al. (2010) Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats. Brain Behav Immun 24: 959-67.
63. Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, et al. (1992) Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 5: 251-6.
64. Fleming JO, Ting JY, Stohlman SA, Weiner LP, (1983) Improvements in obtaining and characterizing mouse cerebrospinal fluid. Application to mouse hepatitis virus-induced encephalomyelitis. J Neuroimmunol 4: 129-140.
65. Che X, Chi F, Wang L, Jong TD, Wu CH, et al. (2010) Involvement of IbeA in meningitic Escherichia coli K1-induced polymorphonuclear leukocyte transmigration across brain endothelial cells. Brain Pathology 21: 389-404.
66. Stastný F, Dvoráková L, Lisý V, (1997) Biochemical characteristics of gamma-glutamyl transpeptidase in capillaries from entorhinohippocampal complex of quinolinate-lesioned rat brain. Mol Chem Neuropathol. 32: 143-61.
67. Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, et al. (2009) A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54: 253-263.
68. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, et al. (2003) Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52: 961-70.
69. Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, et al. (2008) Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res 1203: 133-48.